Wonjun Oh

Wonjun Oh is currently the Director at SEEGENE INC., where they lead the R&D department and developed a real-time PCR based molecular diagnostic kit for detecting Herpes Simplex Virus 1 and 2. Prior to this role, Wonjun served as a Research Teaching Specialist III at Rutgers Robert Wood Johnson Medical School from 2007 to 2012, focusing on the mTOR protein and its implications in various diseases, with their work published in notable journals. Additionally, from 2002 to 2007, Wonjun was a Visiting Fellow at the National Institutes of Health, studying tumor regression mechanisms. They are currently pursuing further education at KAIST.